The AP (2/14, Neergaard) reports that the
Institute of Medicine on Wednesday released a report that concludes, tackling the
"problem of fake drugs will require creating a national drug-tracking
system." The IOM's report calling "for putting medications through a
chain of custody like US courts require for evidence in a trial comes a week
after the Food and Drug Administration warned doctors, for the third time in
about a year, that it discovered a counterfeit batch of the cancer drug Avastin
[bevacizumab] that lacked the real tumor-killing ingredient."
NPR (2/13, Knox) in its "Shots" blog
reports that the "National Academies of Science, of which the IOM is part,
was commissioned by the Food and Drug Administration to look at how to protect
people against fake and substandard drugs." According to the report, the
problem "extends to more than 120 countries...and has done incalculable
damage to efforts to control tuberculosis, malaria, AIDS and other
diseases."
The Wall Street Journal (2/14) "Corporate
Intelligence" notes that the IOM report also emphasized that oversight of
prescription drug wholesalers needs to be strengthened.
AFP (2/14, Santini) adds that FDA Commissioner
Dr. Margaret Hamburg "commended the report" and the agency is already
implementing many of its suggestions. "To meet the challenges of today's
global marketplace, the FDA is transforming from a predominantly domestically
focused agency to one that is fully prepared to help ensure product safety and
quality within a globalized world," Dr. Hamburg said in a statement.
However, according to The Hill (2/14, Wilson) "Regwatch"
blog, "Members of Congress want to create legislation to increase the
crackdown and oversight effort." Rep. Henry Waxman (R-CA), the
"ranking member of the House Energy and Commerce Committee" said
"I hope we can pass a law at the federal level that provides the same
level of protection as California's model legislation," which requires
"individual units of drugs to be accounted for at each step along the
supply chain."
Modern Healthcare (2/13, Zigmond, Subscription
Publication), HealthDay (2/14, Gardner) and MedPage Today (2/14, Pittman) also cover the
reports, which is titled, "Countering the Problem of Falsified and
Substandard Drugs."
from DIA Daily
Subscribe to the DIA Daily.
View archives.
iPhone and iPad Apps available! Download "BulletinHC."DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.
If you would like more information about, or have a question pertaining to, DIA Membership and its benefits, please email membership@diahome.org.Click here to check your membership status.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191
DIA Daily. This daily enewsletter features summaries of breaking news and information about the pharmaceutical, biotechnology, and medical device fields from thousands of global news sources. This easy-to-read enewsletter is delivered to your inbox every business morning. |
Subscribe to the DIA Daily.
View archives.
iPhone and iPad Apps available! Download "BulletinHC."DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.
If you would like more information about, or have a question pertaining to, DIA Membership and its benefits, please email membership@diahome.org.Click here to check your membership status.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191
No comments:
Post a Comment